190 related articles for article (PubMed ID: 16298725)
21. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
22. How does bupropion work as a smoking cessation aid?
Warner C; Shoaib M
Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583
[TBL] [Abstract][Full Text] [Related]
23. Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists.
Sorge RE; Clarke PB
J Pharmacol Exp Ther; 2009 Aug; 330(2):633-40. PubMed ID: 19448141
[TBL] [Abstract][Full Text] [Related]
24. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.
Wooters TE; Neugebauer NM; Rush CR; Bardo MT
Neuropsychopharmacology; 2008 Apr; 33(5):1137-48. PubMed ID: 17581534
[TBL] [Abstract][Full Text] [Related]
25. Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.
O'Dell LE; Chen SA; Smith RT; Specio SE; Balster RL; Paterson NE; Markou A; Zorrilla EP; Koob GF
J Pharmacol Exp Ther; 2007 Jan; 320(1):180-93. PubMed ID: 17050784
[TBL] [Abstract][Full Text] [Related]
26. The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
Shanahan M; Doran C; Gates J; Shakeshaft A; Mattick RP
Appl Health Econ Health Policy; 2003; 2(2):76-8. PubMed ID: 14619277
[No Abstract] [Full Text] [Related]
27. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
28. Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Malcolm E; Carroll FI; Blough B; Damaj MI; Shoaib M
Psychopharmacology (Berl); 2015 Aug; 232(15):2763-71. PubMed ID: 25761841
[TBL] [Abstract][Full Text] [Related]
29. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats.
Dravolina OA; Zakharova ES; Shekunova EV; Zvartau EE; Danysz W; Bespalov AY
Neuropharmacology; 2007 Feb; 52(2):263-9. PubMed ID: 16963088
[TBL] [Abstract][Full Text] [Related]
30. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine.
Suto N; Austin JD; Vezina P
Psychopharmacology (Berl); 2001 Nov; 158(2):175-80. PubMed ID: 11702091
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
Bruijnzeel AW; Markou A
Synapse; 2003 Oct; 50(1):20-8. PubMed ID: 12872290
[TBL] [Abstract][Full Text] [Related]
32. Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement.
Coen KM; Adamson KL; Corrigall WA
Psychopharmacology (Berl); 2009 Jan; 201(4):557-68. PubMed ID: 18795267
[TBL] [Abstract][Full Text] [Related]
33. [ABC of smoking cessation. Bupropion and other drugs in non-nicotine therapy].
Roddy E
Cas Lek Cesk; 2004; 143(12):863-5. PubMed ID: 15730222
[TBL] [Abstract][Full Text] [Related]
34. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
Paul CL; Tzelepis F; Walsh RA; Turner R
Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
[TBL] [Abstract][Full Text] [Related]
35. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336
[TBL] [Abstract][Full Text] [Related]
36. Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats.
Yoshimura RF; Hogenkamp DJ; Li WY; Tran MB; Belluzzi JD; Whittemore ER; Leslie FM; Gee KW
J Pharmacol Exp Ther; 2007 Dec; 323(3):907-15. PubMed ID: 17873105
[TBL] [Abstract][Full Text] [Related]
37. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats.
Vann RE; James JR; Rosecrans JA; Robinson SE
Brain Res; 2006 May; 1086(1):98-103. PubMed ID: 16626643
[TBL] [Abstract][Full Text] [Related]
38. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Paterson NE; Balfour DJ; Markou A
Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
[TBL] [Abstract][Full Text] [Related]
39. Nicotine vaccines for smoking cessation.
Murtagh J; Foerster V
Issues Emerg Health Technol; 2007 Sep; (103):1-4. PubMed ID: 17896445
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Florek E; Piekoszewski W
Przegl Lek; 2008; 65(10):700-5. PubMed ID: 19189582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
